Purpose To describe a case of full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration, which has not been reported to date. Case description A 65-year-old male patient received brolucizumab intravitreal injection therapy for neovascular macular degeneration of the right eye. He received multiple intravitreal anti-VEGF injections on a pro re nata regimen and developed a full thickness macular hole. Outcome Surgical treatment was performed with pars plana vitrectomy of the right eye. Full thickness macular hole was successfully treated. Conclusion Although a full thickness macular hole following intravitreal brolucizumab injection is an uncommon complication, it requires caution.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: